A phase II study with cyclophosphamide, vincristina, non-pegylated liposomal doxorubicin and prednisone plus rituximab, administered in a two weeks regimen (R-COMP-14) as primary treatment for aggressive non-Hodgkin´s lymphoma - Provencio Pulla, Mariano (2007)